Minodronic acid NEW
Price | Get Latest Price |
Package | 25kg |
Min. Order: | 1kg |
Supply Ability: | 1000tons |
Update Time: | 2023-07-28 |
Product Details
Product Name: Minodronic acid | CAS No.: 180064-38-4 |
EC-No.: 1592732-453-0 | Min. Order: 1kg |
Purity: 99% | Supply Ability: 1000tons |
Release date: 2023/07/28 |
Product Name: | Minodronic acid |
Synonyms: | PHOSPHONIC ACID, (1-HYDROXY-2-IMIDAZO(1,2-A)PYRIDIN-3-YLETHYLIDENE)BIS-;1-Hydroxy-2-(imidazo[1,2-a]pyridin-3-yl)ethane-1,1-bis(phosphonic acid);(127657-42-5) minodronic acid;1-Hydroxy-2-(imidazo[1,2-a]pyridin-3-yl)-1,1-ethanediyl]bis(phosphonic acid);(1-Hydroxy-2-imidazo[1,2-A]pyridin-3-yl-1-ethyl)-1,1-bisphos phonate;Nsc725590;Bonoteo;BPH 261 |
CAS: | 180064-38-4 |
MF: | C9H12N2O7P2 |
MW: | 322.15 |
EINECS: | 1592732-453-0 |
Product Categories: | API |
Mol File: | 180064-38-4.mol |
density | 1.97±0.1 g/cm3(Predicted) |
storage temp. | under inert gas (nitrogen or Argon) at 2-8°C |
solubility | Aqueous Base (Slightly), Methanol (Slightly) |
form | Solid |
pka | 1.48±0.10(Predicted) |
color | White to Off-White |
Description | Minodronic acid hydrate, a third-generation bisphosphonate, was approved and launched in Japan for the oral treatment of osteoporosis. Osteoporosis is a skeletal disorder characterized by low bone mass and structural deterioration of bone tissue resulting in bone fragility and increased susceptibility to fractures, particularly of the hip, spine, and wrist. It is the most common type of metabolic bone disease and a major health concern affecting 200 million women worldwide. Minodronic acid is the newest nitrogen-containing bisphosphonate to reach the market. In vitro, it inhibits recombinant human FPP synthase activity with similar potency as zoledronic acid (IC50 = 3 nM for both agents). The most common adverse events associated with minodronic acid included stomach and abdominal discomfort, abdominal pain, decrease in blood calcium level, and gastritis. The chemical synthesis of minodronic acid starts with a condensation reaction of 2-aminopyridine with ethyl 4-bromo-3-oxobutyrate by means of sodium bicarbonate to produce 2-(imidazo[1,2-a]pyridin-3-yl)acetic acid ethyl ester, which is hydrolyzed to the corresponding carboxylic acid with potassium hydroxide. Treatment of the carboxylic acid intermediate with phosphorus acid and phosphorus trichloride followed by hydrolysis with hydrochloric acid gives minodronic acid. |
Company Profile Introduction
-
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$10.00/1kg |
VIP1Y
|
Hebei Zhuanglai Chemical Trading Co.,Ltd
|
2024-06-06 | |
$50.00/1kg |
Ouhuang Engineering Materials (Hubei) Co., Ltd
|
2024-04-23 | ||
$50.00/1kg |
Henan Bao Enluo International TradeCo.,LTD
|
2023-08-15 | ||
$10.00/1KG |
VIP6Y
|
Hebei Weibang Biotechnology Co., Ltd
|
2023-05-11 | |
$1.10/1g |
VIP4Y
|
Dideu Industries Group Limited
|
2021-09-26 | |
$2.00/1kg |
VIP7Y
|
Career Henan Chemical Co
|
2018-12-19 |
- Since: 2017-12-08
- Address: Building A, Enjoy city, Zhongshan East Road, Shijiazhuang city, Hebei province
INQUIRY
xing
13288715578
sales@hbmojin.com
13288715578
sales@hbmojin.com